Merit Medical Systems Net Income 2010-2023 | MMSI
Merit Medical Systems net income from 2010 to 2023. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Merit Medical Systems Annual Net Income
(Millions of US $) |
| 2023 |
$94 |
| 2022 |
$75 |
| 2021 |
$48 |
| 2020 |
$-10 |
| 2019 |
$5 |
| 2018 |
$42 |
| 2017 |
$28 |
| 2016 |
$20 |
| 2015 |
$24 |
| 2014 |
$23 |
| 2013 |
$17 |
| 2012 |
$20 |
| 2011 |
$23 |
| 2010 |
$12 |
| 2009 |
$23 |
Merit Medical Systems Quarterly Net Income
(Millions of US $) |
| 2023-12-31 |
$28 |
| 2023-09-30 |
$26 |
| 2023-06-30 |
$20 |
| 2023-03-31 |
$21 |
| 2022-12-31 |
$33 |
| 2022-09-30 |
$15 |
| 2022-06-30 |
$15 |
| 2022-03-31 |
$11 |
| 2021-12-31 |
$21 |
| 2021-09-30 |
$12 |
| 2021-06-30 |
$5 |
| 2021-03-31 |
$11 |
| 2020-12-31 |
$15 |
| 2020-09-30 |
$-3 |
| 2020-06-30 |
$-19 |
| 2020-03-31 |
$-3 |
| 2019-12-31 |
$-4 |
| 2019-09-30 |
$-3 |
| 2019-06-30 |
$7 |
| 2019-03-31 |
$6 |
| 2018-12-31 |
$9 |
| 2018-09-30 |
$17 |
| 2018-06-30 |
$11 |
| 2018-03-31 |
$5 |
| 2017-12-31 |
$7 |
| 2017-09-30 |
$-4 |
| 2017-06-30 |
$9 |
| 2017-03-31 |
$15 |
| 2016-12-31 |
$8 |
| 2016-09-30 |
$1 |
| 2016-06-30 |
$7 |
| 2016-03-31 |
$4 |
| 2015-12-31 |
$6 |
| 2015-09-30 |
$5 |
| 2015-06-30 |
$7 |
| 2015-03-31 |
$5 |
| 2014-12-31 |
$9 |
| 2014-09-30 |
$8 |
| 2014-06-30 |
$4 |
| 2014-03-31 |
$3 |
| 2013-12-31 |
$7 |
| 2013-09-30 |
$6 |
| 2013-06-30 |
$4 |
| 2013-03-31 |
$1 |
| 2012-12-31 |
$1 |
| 2012-09-30 |
$7 |
| 2012-06-30 |
$6 |
| 2012-03-31 |
$6 |
| 2011-12-31 |
$5 |
| 2011-09-30 |
$5 |
| 2011-06-30 |
$7 |
| 2011-03-31 |
$7 |
| 2010-12-31 |
$4 |
| 2010-09-30 |
$-2 |
| 2010-06-30 |
$6 |
| 2010-03-31 |
$5 |
| 2009-12-31 |
$5 |
| 2009-09-30 |
$6 |
| 2009-06-30 |
$6 |
| 2009-03-31 |
$6 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$4.307B |
$1.257B |
|
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
|
